US stocks on the move: Halozyme, Moderna, Merck

HALO•2026-10-07

Halozyme climbed after a Dutch court win against Merck’s injected Keytruda. Merck shares climbed on a collaboration with Tempus; no specific news was listed for Moderna.

1. Company share moves

Halozyme Therapeutics climbed after a Dutch court win against Merck’s injected Keytruda. Merck shares climbed on a collaboration with Tempus. The article listed Moderna without a related share move or explanation.

US stocks on the move: Halozyme, Moderna, Merck

1. Company share moves

Related News

Dell Technologies introduces XPS 16 Creator Edition laptop powered by Nvidia RTX Spark

Cencora report flags payer restrictions squeezing health-system pharmacy patient access

abrdn Healthcare Investors director Alan R. Goodson sells 242 shares for $4,675.41

First Industrial Realty Trust to host third-quarter 2026 results conference call

Nasdaq halts trading for volatility at 12:54 p.m.